# Specialised - Bleeding Disorders

> Pre-procurement notice from UK public-sector procurement sources.

## Key facts

- Public buyer: [NHS ENGLAND](/buyers/nhs-england/contract-awards)
- Tender value: £92,500,000
- Published: 25 January 2018
- Planned start: 1 July 2018
- Planned end: 30 June 2019
- Stage: pre_procurement
- Notice ID: db1110d5-a4a8-4c3e-a7da-0551561f7c36-193762
- OCID: ocds-b5fd17-17fee10a-d979-4ff2-be14-776496a52cfd

## Description

The products to be included in the procurement exercise are: Recombinant factor VIIa, PDFVIII containing vWF concentrate, PDFIX concentrate, PD pure vWF concentrate, PD Factor VIII Inhibitor Bypassing Fraction \(FEIBA\), PD Factor XIII concentrate, PD Protein C Concentrate, PD Fibrinogen concentrate, Fresh Frozen Plasma, PD FX concentrate, Recombinant Porcine Factor VIII concentrate, Prothrombin Complex Concentrate, Emicizumab \(humanised bispecific antibody\)\.

## Related contract awards

- [Transformation Delivery Services - Establishing Operational Excellence \(EOE\)](/contracts/ocds-b5fd17-b08595d2-8961-409b-9b62-7b01d7a64541): NHS England
- [Identity Access Management - Service Adoption and Enablement](/contracts/ocds-b5fd17-08ebad6c-84fb-4e62-9afd-d06d220dd3a5): NHS England
- [OutSystems licenses for MAPPTI \(AP&P\)](/contracts/ocds-b5fd17-521fbf90-6e93-4366-b3bc-47aa2efd447d): NHS England

## Source

[View the original notice on Contracts Finder](https://www.contractsfinder.service.gov.uk/Notice/db1110d5-a4a8-4c3e-a7da-0551561f7c36-193762)